Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | SEA-BCMA |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
SEA-BCMA is a humanized antibody against BCMA, which may increase antibody-dependent cellular cytotoxicity and cellular phagocytosis and decrease proliferation, potentially leading to decreased tumor growth (Cancer Res July 1 2018 (78) (13 Supplement) 3833). |
| DrugClasses | TNFRSF17 Antibody 22 |
| CAS Registry Number | 2115084-53-0 |
| NCIT ID | C148176 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ACTR087 + SEA-BCMA | ACTR087 SEA-BCMA | 0 | 1 |
| Dexamethasone + SEA-BCMA | Dexamethasone SEA-BCMA | 0 | 0 |
| SEA-BCMA | SEA-BCMA | 0 | 1 |